Lipriom, Lipriom-A & Lipriom-Gold – Rosuvastatin & Combination Therapy

The Lipriom Range is designed for comprehensive management of dyslipidemia and prevention of cardiovascular events.

Lipriom (Rosuvastatin) provides effective lipid control and supports regression of atherosclerosis. Lipriom-A (Rosuvastatin + Aspirin) offers dual-action therapy for primary prevention of heart attack and stroke. Lipriom-Gold (Rosuvastatin + Aspirin + Clopidogrel) delivers advanced triple therapy for high-risk patients, including those with acute coronary syndrome and post-cardiac events.

Together, the Lipriom range ensures better lipid control, reduced cardiovascular risk, and long-term heart protection.

🔹 Key Benefits

• Comprehensive lipid and cardiovascular risk management
• Reduces LDL cholesterol and oxidative stress
• Supports atherosclerosis regression
• Prevents heart attack and stroke
• Dual and triple therapy for high-risk patients
• Improves long-term cardiovascular outcomes

🔹 Indications

• Dyslipidemia
• Atherosclerosis
• Primary prevention of heart attack and stroke
• Acute coronary syndrome (ACS)
• Post-myocardial infarction
• High cardiovascular risk patients

🔹 Composition

Lipriom

• Rosuvastatin 10 mg / 20 mg

Lipriom-A

• Rosuvastatin 10 mg
• Aspirin 75 mg

Lipriom-Gold

• Rosuvastatin 10 mg
• Aspirin 75 mg
• Clopidogrel 75 mg